Stulnig, Thomas M.

The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response

Weichhart, T., Costantino, G., Poglitsch, M., Rosner, M., Zeyda, M., Stuhlmeier, K. M., Kolbe, T., Stulnig, T. M., Hörl, W. H., Hengstschläger, M., et al. (2008) · Immunity

Immune Response and InflammationPI3K/AKT/mTOR signaling in cancer

Cited by 801

The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells

Bruschi, F. V., Claudel, T., Tardelli, M., Caligiuri, A., Stulnig, T. M., Marra, F., & Trauner, M. (2017) · Hepatology

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 268

Activated Liver X Receptors Stimulate Adipocyte Differentiation through Induction of Peroxisome Proliferator-Activated Receptor γ Expression

Seo, J. B., Moon, H. M., Kim, W. S., Lee, Y. S., Jeong, H. W., Yoo, E. J., Ham, J., Kang, H., Park, M.-G., Steffensen, K. R., et al. (2004) · Molecular and Cellular Biology

Peroxisome Proliferator-Activated ReceptorsCholesterol and Lipid Metabolism

Cited by 250

Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: A randomized controlled trial

Itariu, B. K., Zeyda, M., Hochbrugger, E. E., Neuhofer, A., Prager, G., Schindler, K., Bohdjalian, A., Mascher, D., Vangala, S., Schranz, M., et al. (2012) · The American Journal of Clinical Nutrition

Fatty Acid Research and HealthAdipokines, Inflammation, and Metabolic Diseases

Cited by 227

Neutralization of Osteopontin Inhibits Obesity-Induced Inflammation and Insulin Resistance

Kiefer, F. W., Zeyda, M., Gollinger, K., Pfau, B., Neuhofer, A., Weichhart, T., Säemann, M. D., Geyeregger, R., Schlederer, M., Kenner, L., et al. (2010) · Diabetes

Adipokines, Inflammation, and Metabolic DiseasesBone and Dental Protein Studies

Cited by 200

Autoimmune Aspects of Type 2 Diabetes Mellitus - A Mini-Review

Itariu, B. K., & Stulnig, T. M. (2014) · Gerontology

Diabetes and associated disordersT-cell and B-cell Immunology

Cited by 107

Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice

Kiefer, F. W., Neschen, S., Pfau, B., Legerer, B., Neuhofer, A., Kahle, M., Hrabé de Angelis, M., Schlederer, M., Mair, M., Kenner, L., et al. (2011) · Diabetologia

Liver Disease Diagnosis and TreatmentAdipokines, Inflammation, and Metabolic Diseases

Cited by 104

Serum Myostatin is Upregulated in Obesity and Correlates with Insulin Resistance in Humans

Amor, M., Itariu, B. K., Moreno-Viedma, V., Keindl, M., Jürets, A., Prager, G., Langer, F., Grablowitz, V., Zeyda, M., & Stulnig, T. M. (2019) · Experimental and Clinical Endocrinology & Diabetes

Adipokines, Inflammation, and Metabolic DiseasesMuscle Physiology and Disorders

Cited by 93

Effectiveness and safety of bempedoic acid in routine clinical practice: 1-year follow-up snapshot of the MILOS German cohort

Gouni-Berthold, I., Koskinas, K., Averna, M., Stulnig, T., Vanassche, T., Blackburn, C., Smolnik, R., Soronen, J., Wenz-Poschl, K., Pinto, X., et al. (2023) · European Heart Journal

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 6